HomeASRT • NASDAQ
Assertio Holdings Inc
$0.81
0.38%
-0.0031 Today
After Hours:
$0.80
(1.54%)-0.012
Closed: Sep 4, 7:31:04 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
020M
Revenue
Net Income
Revenue
Net income
(USD)Jun 2025Y/Y change
Revenue
29.22M-6.12%
Operating expense
25.28M-2.22%
Net income
-16.35M-345.07%
Net profit margin
-55.96-374.24%
Earnings per share
0.020.00%
EBITDA
5.03M40.01%
Effective tax rate
-0.34%
0100M200M
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD)Jun 2025Y/Y change
Cash and short-term investments
98.18M11.09%
Total assets
273.78M-2.03%
Total liabilities
180.48M22.54%
Total equity
93.30M
Shares outstanding
96.24M
Price to book
0.84
Return on assets
-3.78%
Return on capital
-7.50%
-20M0
Net Change in Cash
Net change in cash
(USD)Jun 2025Y/Y change
Net income
-16.35M-345.07%
Cash from operations
19.09M158.44%
Cash from investing
-6.94M83.98%
Cash from financing
-69.00K8.00%
Net change in cash
12.08M133.55%
Free cash flow
25.38M219.78%
StockUS listed securityUS headquartered
Previous close
$0.81
Day range
$0.79 - $0.82
Year range
$0.51 - $1.38
Market cap
77.75M USD
Avg Volume
243.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration. On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Wikipedia
Founded
1995
Employees
58
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Finance
Search
Clear search
Close search
Main menu
Google apps